We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Partnership to Develop New Prostate Cancer Diagnostic

By HospiMedica staff writers
Posted on 10 Sep 2003
Under an agreement to develop new tools for diagnosing prostate cancer, DakoCytomation (Copenhagen, Denmark) has received a worldwide license for the commercial use of an antibody of Northwest Therapeutics (Bothell, WA, USA) that recognizes the key prostate cancer marker, prostate specific membrane antigen (PSMA).

PSMA is a glycoprotein expressed in virtually all prostate cancers that will be useful in diagnosing and confirming prostate cancer and may also be useful as a marker for angiogenesis in other cancers. More...
DykoCytomation currently offers tissue-staining antibodies specific to two other well-established prostate cancer markers: prostate-specific antigen (PSA) and prostate-specific acid phosphatase (PAP). In addition, the company offers three serum tests for PSA.

"DakoCytomation is proud to add the PSMA antibody to our growing line of clinically relevant prostate cancer markers,” said Dennis Chenoweth, corporate vice president of diagnostics at DakoCytomation. "We will continue to expand our portfolio of cancer markers to aid in the management of all cancer types.”





Related Links:
DakoCytomation
Northwest Therapeutics

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.